Granules India Limited (GRANULES) — Announcement

· NSE Neutral
📢 Key Event
Monitoring agency confirmed no deviation in fund utilization
💡 Investor Takeaway
Shareholders can view this as confirmation that preferential issue funds are being used as disclosed without material deviations.

Granules India disclosed that India Ratings & Research confirmed no deviation from the stated utilization of proceeds from its INR 1,762.50 crore preferential issue, with funds deployed across business operations and convertible warrants. The monitoring report validated that 300 crores were used for term loan prepayment in a subsidiary, while 1,462.50 crores remained allocated to other purposes including working capital and vendor payments. No material delays or changes were noted, and the company confirmed adherence to all regulatory requirements.

📄 View Original Announcement (PDF)

About Granules India Limited (GRANULES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹18,242.81 Cr P/E: 37.2

View full GRANULES stock details →

📡 Get AI alerts when GRANULES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GRANULES — Free

📊 More GRANULES filings

See all GRANULES filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GRANULES files new disclosures

Track GRANULES filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GRANULES — Free

Free account · 2 AI queries/day